186 related articles for article (PubMed ID: 9187363)
1. Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation.
Thibault V; Richards CD; Botelho F; Gauldie J
FEBS Lett; 1997 May; 408(2):182-6. PubMed ID: 9187363
[TBL] [Abstract][Full Text] [Related]
2. Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor.
Thibault V; Terlain B; Gauldie J
J Interferon Cytokine Res; 1996 Nov; 16(11):973-81. PubMed ID: 8938575
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes.
Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA
Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121
[TBL] [Abstract][Full Text] [Related]
4. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
Nishimura R; Moriyama K; Yasukawa K; Mundy GR; Yoneda T
J Bone Miner Res; 1998 May; 13(5):777-85. PubMed ID: 9610741
[TBL] [Abstract][Full Text] [Related]
5. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
6. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
Geisterfer M; Richards CD; Gauldie J
Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tissue inhibitor of metalloproteinase-1 in fibroblasts and acute phase proteins in hepatocytes in vitro by mouse oncostatin M, cardiotrophin-1, and IL-6.
Richards CD; Kerr C; Tanaka M; Hara T; Miyajima A; Pennica D; Botelho F; Langdon CM
J Immunol; 1997 Sep; 159(5):2431-7. PubMed ID: 9278335
[TBL] [Abstract][Full Text] [Related]
8. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors.
Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
J Immunol Methods; 1994 Aug; 173(2):229-35. PubMed ID: 8046256
[TBL] [Abstract][Full Text] [Related]
10. Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements.
Lai CF; Ripperger J; Morella KK; Jurlander J; Hawley TS; Carson WE; Kordula T; Caligiuri MA; Hawley RG; Fey GH; Baumann H
J Biol Chem; 1996 Jun; 271(24):13968-75. PubMed ID: 8662928
[TBL] [Abstract][Full Text] [Related]
11. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.
Ward LD; Hammacher A; Howlett GJ; Matthews JM; Fabri L; Moritz RL; Nice EC; Weinstock J; Simpson RJ
J Biol Chem; 1996 Aug; 271(33):20138-44. PubMed ID: 8702737
[TBL] [Abstract][Full Text] [Related]
12. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.
Dahmen H; Horsten U; Küster A; Jacques Y; Minvielle S; Kerr IM; Ciliberto G; Paonessa G; Heinrich PC; Müller-Newen G
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):695-702. PubMed ID: 9560294
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor.
Hooper WC; Phillips DJ; Evatt BL
Thromb Haemost; 1997 May; 77(5):1014-9. PubMed ID: 9184420
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
15. Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells.
Oh JW; Katz A; Harroch S; Eisenbach L; Revel M; Chebath J
Oncogene; 1997 Jul; 15(5):569-77. PubMed ID: 9247310
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.
Legendre F; Bogdanowicz P; Boumediene K; Pujol JP
J Rheumatol; 2005 Jul; 32(7):1307-16. PubMed ID: 15996070
[TBL] [Abstract][Full Text] [Related]
17. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
18. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
[TBL] [Abstract][Full Text] [Related]
19. STAT3 is constitutively activated in Hodgkin cell lines.
Kube D; Holtick U; Vockerodt M; Ahmadi T; Haier B; Behrmann I; Heinrich PC; Diehl V; Tesch H
Blood; 2001 Aug; 98(3):762-70. PubMed ID: 11468177
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of a replication-deficient adenovirus expressing rat-soluble interleukin-6 receptor.
Thibault V; Terlain B; Graham FL; Gauldie J
Mol Med; 1997 Aug; 3(8):519-29. PubMed ID: 9307980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
